Literature DB >> 19516271

Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach.

L C Y Poon1, N A Kametas, T Chelemen, A Leal, K H Nicolaides.   

Abstract

The study aimed to develop prediction algorithms for hypertensive disorders based on multivariate analysis of factors from the maternal history and compare the estimated performance of such algorithms in the prediction of early preeclampsia (PE), late-PE and gestational hypertension (GH) with that recommended by the National Institute for Clinical Excellence (NICE). Logistic regression analysis was used to determine which of the maternal characteristics and history had significant contribution in predicting early-PE, late-PE and GH. There were 37 cases with early-PE, 128 with late-PE, 140 with GH and 8061 cases that were unaffected by PE or GH. Predictors of early-PE were Black race, chronic hypertension, prior PE and use of ovulation drugs. Predictors of late-PE and GH were increased maternal age and body mass index, and family history or history of PE. Additionally, late-PE was more common in Black, Indian and Pakistani women. The detection rates of early-PE, late-PE and GH in screening by maternal factors were 37.0, 28.9 and 20.7%, respectively, for a 5% false positive rate. Screening as suggested by NICE would have resulted in a false positive rate of 64.1% with detection rates of 89.2, 93.0 and 85.0% for early-PE, late-PE and GH, respectively. Meaningful screening for hypertensive disorders in pregnancy by maternal history necessitates the use of algorithms derived by logistic regression analysis.

Entities:  

Mesh:

Year:  2009        PMID: 19516271     DOI: 10.1038/jhh.2009.45

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  52 in total

Review 1.  Extracellular nucleic acids in maternal circulation as potential biomarkers for placental insufficiency.

Authors:  Ilona Hromadnikova
Journal:  DNA Cell Biol       Date:  2012-02-24       Impact factor: 3.311

2.  Aspirin in the prevention of preeclampsia: the conundrum of how, who and when.

Authors:  Renuka Shanmugalingam; Annemarie Hennessy; Angela Makris
Journal:  J Hum Hypertens       Date:  2018-09-19       Impact factor: 3.012

3.  The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.

Authors:  Liona C Poon; Andrew Shennan; Jonathan A Hyett; Anil Kapur; Eran Hadar; Hema Divakar; Fionnuala McAuliffe; Fabricio da Silva Costa; Peter von Dadelszen; Harold David McIntyre; Anne B Kihara; Gian Carlo Di Renzo; Roberto Romero; Mary D'Alton; Vincenzo Berghella; Kypros H Nicolaides; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2019-05       Impact factor: 3.561

4.  The use of ultrasound and other markers for early detection of preeclampsia.

Authors:  Neil O'Gorman; Kypros H Nicolaides; Liona C Y Poon
Journal:  Womens Health (Lond)       Date:  2016-02-22

Review 5.  First trimester screening for pre-eclampsia.

Authors:  Stefan C Kane
Journal:  Obstet Med       Date:  2016-05-14

Review 6.  New approaches for managing preeclampsia: clues from clinical and basic research.

Authors:  Eric M George
Journal:  Clin Ther       Date:  2014-11-20       Impact factor: 3.393

7.  Preeclampsia: Linking Placental Ischemia with Maternal Endothelial and Vascular Dysfunction.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Heather A Drummond; Babbette LaMarca; Michael J Ryan; Joey P Granger
Journal:  Compr Physiol       Date:  2020-12-09       Impact factor: 9.090

8.  Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia.

Authors:  Giovanna Ogge; Tinnakorn Chaiworapongsa; Roberto Romero; Youssef Hussein; Juan Pedro Kusanovic; Lami Yeo; Chong Jai Kim; Sonia S Hassan
Journal:  J Perinat Med       Date:  2011-08-17       Impact factor: 1.901

9.  Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model.

Authors:  Mark K Santillan; Donna A Santillan; Sabrina M Scroggins; James Y Min; Jeremy A Sandgren; Nicole A Pearson; Kimberly K Leslie; Stephen K Hunter; Gideon K D Zamba; Katherine N Gibson-Corley; Justin L Grobe
Journal:  Hypertension       Date:  2014-07-07       Impact factor: 10.190

10.  Risk factors of hypertensive disorders among Chinese pregnant women.

Authors:  Rong Hu; Ying-Xue Li; Hai-Hong Di; Zhi-Wei Li; Chun-Hua Zhang; Xian-Ping Shen; Jun-Feng Zhu; Wei-Rong Yan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.